Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2014. Start Trial.
Date Value
October 30, 2026 2.084M
October 29, 2026 1.707M
October 28, 2026 2.310M
October 27, 2026 2.159M
October 26, 2026 1.330M
October 23, 2026 0.6508M
October 22, 2026 0.9525M
October 21, 2026 0.8017M
October 20, 2026 0.6508M
October 19, 2026 1.631M
October 16, 2026 0.3491M
October 15, 2026 -0.1789M
October 14, 2026 0.0474M
October 13, 2026 0.3491M
October 12, 2026 1.254M
October 09, 2026 1.782M
October 08, 2026 0.9525M
October 07, 2026 1.858M
October 06, 2026 2.159M
October 05, 2026 2.159M
October 02, 2026 2.310M
October 01, 2026 2.386M
September 30, 2026 2.763M
September 29, 2026 2.914M
September 28, 2026 2.914M
Date Value
September 25, 2026 3.404M
September 24, 2026 3.442M
September 23, 2026 3.592M
September 22, 2026 3.592M
September 21, 2026 3.592M
September 18, 2026 3.442M
September 17, 2026 4.724M
September 16, 2026 4.271M
September 15, 2026 4.498M
September 14, 2026 6.760M
September 11, 2026 5.855M
September 10, 2026 5.704M
September 09, 2026 6.157M
September 08, 2026 6.911M
September 04, 2026 6.383M
September 03, 2026 6.610M
September 02, 2026 6.610M
September 01, 2026 8.193M
August 31, 2026 8.495M
August 28, 2026 7.59M
August 27, 2026 7.816M
August 26, 2026 7.213M
August 25, 2026 7.062M
August 24, 2026 7.439M
August 21, 2026 6.006M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Agenus, Inc. 556.15M
Amgen, Inc. 295.24B
Anika Therapeutics, Inc. 267.21M
BioCryst Pharmaceuticals, Inc. 2.646B
Imunon, Inc. 5.227M

Enterprise Value Related Metrics